South and Central America Cell Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others) and Country Category : Biotechnology

No. of Pages: 123    |    Report Code: TIPRE00019135    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America Cell Therapy Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Cell Therapy Market – By Therapy Type

1.3.2        South and Central America Cell Therapy Market – By Product

1.3.3        South and Central America Cell Therapy Market – By Technology

1.3.4        South and Central America Cell Therapy Market – By Application

1.3.5        South and Central America Cell Therapy Market – By End User

1.3.6        South and Central America Cell Therapy market – By Countries

2.           South and Central America Cell Therapy Market –  Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Cell Therapy Market –  Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Cell Therapy Market - South and Central America PEST Analysis

4.3         Expert Opinion

5.           South and Central America Cell Therapy Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Rising Adoption of Regenerative Medicines

5.1.3        Increasing Number of Approvals for Cell-Based Therapies

5.2         Key Market Restraints

5.2.1        High Cost of Cell Therapy Manufacturing

5.3         Key Market Opportunities

5.3.1        Increasing Adoption of Cell Therapy in South America Regions

5.4         Future Trends

5.4.1        Shift Toward Automated Cell Therapy Manufacturing

5.5         Impact Analysis of Drivers and Restraints

6.           Cell Therapy Market –  South and Central America Analysis

6.1         South and Central America Cell Therapy Market Revenue Forecast And Analysis

6.2         South and Central America Cell Therapy Market, By Countries - Forecast And Analysis

6.3         Market Positioning of Key Players

7.           South and Central America Cell Therapy Market Analysis – By Therapy Type

7.1         Overview

7.2         South and Central America Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)

7.3         Allogeneic

7.3.1        Overview

7.3.1.1          Allogeneic: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)

7.4         Autologous

7.4.1        Overview

7.4.1.1          Autologous: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)

8.           South and Central America Cell Therapy Market Analysis – By Product

8.1         Overview

8.2         Cell Therapy Market Revenue Share, by Product (2019 and 2027)

8.3         Consumables

8.3.1        Overview

8.3.1.1          Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

8.4         Equipment

8.4.1        Overview

8.4.1.1          Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

8.5         Systems and Software

8.5.1        Overview

8.5.1.1          Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

9.           South and Central America Cell Therapy Market Analysis – By Technology

9.1         Overview

9.2         South and Central America Cell Therapy Market Share, by Technology, 2019 and 2027, (%)

9.3         Viral vector Technology

9.3.1        Overview

9.3.1.1          Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

9.4         Genome Editing Technology

9.4.1        Overview

9.4.1.1          Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

9.5         Somatic Cell Technology

9.5.1        Overview

9.5.1.1          Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

9.6         Cell Immortalization Technology

9.6.1        Overview

9.6.2        Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.7         Cell Plasticity Technology

9.7.1        Overview

9.7.2        Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

9.8         Three-Dimensional Technology

9.8.1        Overview

9.8.2        Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

10.        South and Central America cell therapy market Analysis – By Application

10.1      Overview

10.2      South and Central America cell therapy market Revenue Share, by Application (2019 and 2027)

10.3      Oncology

10.3.1     Overview

10.3.2     Oncology: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

10.4      Cardiovascular

10.4.1     Overview

10.4.2     Cardiovascular: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

10.5      Orthopedic

10.5.1     Overview

10.5.2     Orthopedic: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

10.6      Wound Management

10.6.1     Overview

10.6.2     Wound Management: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

10.7      Other Applications

10.7.1     Overview

10.7.2     Other Applications: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

11.        South and Central America cell therapy market Analysis – By End User

11.1      Overview

11.2      South and Central America cell therapy market Share, by End User, 2019 and 2027, (%)

11.3      Hospitals

11.3.1     Overview

11.3.2     Hospitals: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

11.4      Research Institutes

11.4.1     Overview

11.4.2     Research Institutes: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

11.5      Others

11.5.1     Overview

11.5.2     Others: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

12.        South and Central America Cell Therapy Market Analysis And Forecasts To 2027 – Regional Analysis

12.1      South and Central America: Cell Therapy Market

12.1.1     Overview

12.1.2     South and Central America: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

12.1.3     South and Central America: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)

12.1.4     South and Central America: Cell Therapy Market, by Product, 2018–2027 (USD Million)

12.1.5     South and Central America: Cell Therapy Market, by Technology 2018–2027 (USD Million)

12.1.6     South and Central America: Cell Therapy Market, by Application 2018–2027 (USD Million)

12.1.7     South and Central America: Cell Therapy Market, by End User, 2018–2027 (USD Million)

12.1.8     South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)

12.1.9     Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.1       Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

12.1.9.2       Brazil: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)

12.1.9.3       Brazil: Cell Therapy Market, by Product, 2018–2027 (USD Million)

12.1.9.4       Brazil: Cell Therapy Market, by Technology 2018–2027 (USD Million)

12.1.9.5       Brazil: Cell Therapy Market, by Application 2018–2027 (USD Million)

12.1.9.6       Brazil: Cell Therapy Market, by End User, 2018–2027 (USD Million)

12.1.10  Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.1    Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

12.1.10.2    Argentina: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Million)

12.1.10.3    Argentina: Cell Therapy Market, by Product, 2018–2027 (USD Million)

12.1.10.4    Argentina: Cell Therapy Market, by Technology 2018–2027 (USD Million)

12.1.10.5    Brazil: Cell Therapy Market, by Application 2018–2027 (USD Million)

12.1.10.6    Brazil: Cell Therapy Market, by End User, 2018–2027 (USD Million)

13.        Impact of COVID-19 Pandemic on South and Central America Cell Therapy Market

13.1      South and Central America: Impact Assessment of COVID-19 Pandemic

14.        Company Profiles

14.1      NuVasive, Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Smith & Nephew

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Bristol-Myers Squibb Company

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.3.7     SWOT Analysis

14.3.8     Key Developments

14.4      Cells for Cells

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms


LIST OF TABLES

Table 1.             South and Central America Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             South and Central America Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 3.             South and Central America Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 4.             South and Central America Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             South and Central America Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             Brazil Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             Brazil Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 8.             Brazil Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 9.             Brazil Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          Brazil Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Argentina Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Argentina Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 13.          Argentina Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 14.          Brazil Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Brazil Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Glossary of Terms, Cell Therapy Market


LIST OF FIGURES

Figure 1.           Cell Therapy Market Segmentation

Figure 2.           South and Central America Cell Therapy Market Segmentation – By Countries

Figure 3.           South and Central America Cell Therapy Market Overview

Figure 4.           Allogeneic Therapy Type Segment Held Largest Share of South and Central America Cell Therapy Market

Figure 5.           Cell Therapy Market - South and Central America PEST Analysis

Figure 6.           South and Central America Cell Therapy Market Impact Analysis of Drivers and Restraint

Figure 7.           South and Central America Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027 (US$ Million)

Figure 8.           South and Central America Cell Therapy Market – By Countries Forecast and Analysis – 2019- 2027

Figure 9.           Market Positioning Of Key Players In South and Central America Cell Therapy Market

Figure 10.        South and Central America Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)

Figure 11.        Allogeneic: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)

Figure 12.        Autologous: South and Central America Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)

Figure 13.        Cell Therapy Market Revenue Share, by Product (2019 and 2027)

Figure 14.        Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 15.        Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 16.        Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 17.        South and Central America Cell Therapy Market Share, by technology, 2019 and 2027 (%)

Figure 18.        Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 19.        Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 20.        Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)

Figure 21.        Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        South and Central America cell therapy market Revenue Share, by Application (2019 and 2027)

Figure 25.        Oncology: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Cardiovascular: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Orthopedic: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Wound Management: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Other Applications: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        South and Central America cell therapy market Share, by End User, 2019 and 2027 (%)

Figure 31.        Hospitals South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Research Institutes: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Others: South and Central America cell therapy market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        South and Central America: Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)

Figure 35.        South and Central America Cell Therapy Market Revenue and Forecast to 2027 (USD Million)

Figure 36.        South and Central America: Cell Therapy Market, by Country, 2019 & 2027 (%)

Figure 37.        Brazil: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 38.        Argentina: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)

Figure 39.        Impact of COVID-19 Pandemic in South and Central America Country Markets

The List of Companies - South and Central America Cell Therapy Market

  1. NuVasive, Inc.
  2. Smith & Nephew
  3. Bristol-Myers Squibb Company
  4. Cells for Cells